Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

PaperCitations, authors & open-access status

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 161 citations, 2021 year and green oa status.

161
Citations
2021
Year
green
OA Status

Related on ScholarIQ

Frank Kleinjung
Author
The Lancet Respiratory Medicine
Journal
Pulmonary Hypertension Research and Treatments
Topic
Pulmonary Hypertension Research and Treatments
Topic
Phosphodiesterase function and regulation
Topic
Heart Failure Treatment and Management
Topic
470M+ articles · free account